Category: Danaher Corp.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Zimmer proposes divestitures for EU regulators in Biomet deal; China, South Korea OK Medtronic's $43B Covidien buy; BTG to buy PneumRx for up to $475m; BD prices $6.2B bond issue for CareFusion buy; Danaher's Leica division closes Devicor Medical buy
, Becton Dickinson & Co.
, CareFusion Corp.
, Danaher Corp.
, Devicor Medical Products
, European Commission
, Leica Biosystems
, PneumRx Inc.
Danaher's Leica Biosystems division closes its buyout of Devicor Medical Products, a developer of breast biopsy products, for an undisclosed amount.
Danaher's Leica Biosystems division agrees to buy Devicor Medical Products, a developer of breast biopsy products.
Danaher (NYSE:DHR) said today that its Leica Biosystems division agreed to buy Devicor Medical Products, a developer of breast biopsy products.
The $2.14 billion acquisition of Nobel Biocare will turn Danaher into the largest dental implants provider in the world.
Here's a look at some of the top Wall Street stories for medical device companies this week: Covidien snaps up Reverse Medical; Standard & Poor's maintains credit watch on Medtronic over Covidien buy; Allergan can't delay shareholder vote on hostile Valeant bid; Medtronic drops $200M on Dutch DBS firm Sapiens; Nobel Biocare's Q2 profits double as it fields buyout interest
, Danaher Corp.
, Dentsply International Inc.
, Nobel Biocare Holdings AG
, Pershing Square Capital Management
, Reverse Medical Corp.
, Sapiens Brain Steering Stimulation GmbH
, Standard & Poor's
, Valeant Pharmaceuticals
, Allergan Inc.
Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter